Online Appointment Booking
APAC · 1 shared keyword
APAC Femtech Market Industry Trends and Forecast to 2034: Segmented by (Type, Product, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$21.39 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $6.89 Bn | — | — |
| 2025 (base) | $7.96 Bn | +$1.07 Bn | — |
| 2026 (forecast) | $9.20 Bn | +$1.24 Bn | +15.6% |
| 2027 (forecast) | $10.64 Bn | +$1.44 Bn | +33.6% |
| 2028 (forecast) | $12.30 Bn | +$1.66 Bn | +54.5% |
| 2029 (forecast) | $14.22 Bn | +$1.92 Bn | +78.6% |
| 2030 (forecast) | $16.43 Bn | +$2.22 Bn | +106.4% |
| 2031 (forecast) | $19.00 Bn | +$2.56 Bn | +138.6% |
| 2032 (forecast) | $21.96 Bn | +$2.96 Bn | +175.9% |
| 2033 (forecast) | $25.39 Bn | +$3.43 Bn | +218.9% |
| 2034 (forecast) | $29.35 Bn | +$3.96 Bn | +268.7% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $7.96 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $29.35 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 15.6% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Type, product and end user (see all) |
| Key players | Flo Health, Clue (BioWink), Maven Clinic, Elvie (Chiaro), Natural Cycles and 1 more (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Femtech covers apps, devices and services built for women's health, from period tracking to fertility, pregnancy, menopause and pelvic health.
Key segments of the femtech market include type (Period and Fertility Tracking, Pregnancy and Nursing Care and Pelvic Health) and product (Apps, Wearables and Connected Devices).
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the femtech market. New products designed around women's biology and digital care are improving access.
Femtech, personalised care and new treatments for under-served conditions open strong growth for the femtech market, especially as employers and payers add women's health benefits.
Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the femtech market.
The femtech market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, rules for health software come from TGA (Australia)[1], NMPA (China)[2] and PMDA (Japan)[3]. How care is paid for in some of these countries: Medicare and the PBS (Australia)[4], basic medical insurance (China)[5], the Hospital Authority (Hong Kong)[6], Ayushman Bharat PM-JAY (India)[7], public health insurance (Japan)[8], subsidised public care (Malaysia)[9], Pharmac (New Zealand)[10], PhilHealth (Philippines)[11], MediShield Life (Singapore)[12] and the Universal Coverage Scheme (Thailand)[13].
[1] Therapeutic Goods Administration. Checked 14 Nov 2026.
[2] National Medical Products Administration. Checked 14 Nov 2026.
[3] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
[4] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
[5] National Healthcare Security Administration. Checked 14 Nov 2026.
[6] Hospital Authority. Checked 14 Nov 2026.
[7] National Health Authority (PM-JAY). Checked 14 Nov 2026.
[8] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.
[9] Ministry of Health Malaysia. Checked 14 Nov 2026.
[10] Pharmac. Checked 14 Nov 2026.
[11] PhilHealth. Checked 14 Nov 2026.
[12] CPF Board, MediShield Life. Checked 14 Nov 2026.
[13] National Health Security Office. Checked 14 Nov 2026.
Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the femtech market. Government digital health programs in APAC are speeding up adoption.
What doctors and scientists are doing in Femtech right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
APAC · 1 shared keyword
APAC · 1 shared keyword
APAC · 1 shared keyword
APAC · 1 shared keyword
APAC · 1 shared keyword
APAC
Pharmaceuticals · APAC
Healthcare Services · APAC
Pharmaceuticals · APAC
Medical Devices · APAC
Pharmaceuticals · APAC
Pharmaceuticals · APAC